Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance
- PMID: 38366290
- DOI: 10.1007/s11033-024-09288-w
Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance
Abstract
The DNA damage response (DDR) is a crucial cellular signaling pathway activated in response to DNA damage, including damage caused by chemotherapy. Chemoresistance, which refers to the resistance of cancer cells to the effects of chemotherapy, poses a significant challenge in cancer treatment. Understanding the relationship between DDR and chemoresistance is vital for devising strategies to overcome this resistance and improve treatment outcomes. Long non-coding RNAs (lncRNAs) are a class of RNA molecules that do not code for proteins but play important roles in various biological processes, including cancer development and chemoresistance. RNA-binding proteins (RBPs) are a group of proteins that bind to RNA molecules and regulate their functions. The interaction between lncRNAs and RBPs has been found to regulate gene expression at the post-transcriptional level, thereby influencing various cellular processes, including DDR signaling pathways. Multiple studies have demonstrated that lncRNAs can interact with RBPs to modulate the expression of genes involved in cancer chemoresistance by impacting DDR signaling pathways. Conversely, RBPs can regulate the expression and function of lncRNAs involved in DDR. Exploring these interactions can provide valuable insights for the development of innovative therapeutic approaches to overcome chemoresistance in cancer patients. This review article aims to summarize recent research on the interaction between lncRNAs and RBPs during cancer chemotherapy, with a specific focus on DDR pathways.
Keywords: Cancer; Chemoresistance; DNA damage response (DDR); Long non-coding RNAs (lncRNAs); RNA-binding proteins (RBPs).
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
References
-
- Su M, Wang H, Wang W, Wang Y, Ouyang L, Pan C et al (2018) LncRNAs in DNA damage response and repair in cancer cells. Acta Biochim Biophys Sin 50(5):433–439 - PubMed
-
- Adriaens C, Standaert L, Barra J, Latil M, Verfaillie A, Kalev P et al (2016) p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nat Med 22(8):861–868 - PubMed
-
- Özeş AR, Miller DF, Özeş ON, Fang F, Liu Y, Matei D et al (2016) NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene 35(41):5350–5361 - PMC
-
- Xiao H, Liu Y, Liang P, Wang B, Tan H, Zhang Y et al (2018) TP53TG1 enhances cisplatin sensitivity of non-small cell lung cancer cells through regulating miR-18a/PTEN axis. Cell Biosci 8(1):1–13
-
- Astanehe A, Finkbeiner M, Hojabrpour P, To K, Fotovati A, Shadeo A et al (2009) The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1. Oncogene 28(25):2406–2418 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
